These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

145 related articles for article (PubMed ID: 17636476)

  • 1. Combined neonatal blood transplants in a parent-to-F1 mouse model: improved survival rates and stable long-term engraftment.
    Scaradavou A; Sung D; Rubinstein P
    Am J Hematol; 2007 Nov; 82(11):961-9. PubMed ID: 17636476
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Protective conditioning against GVHD and graft rejection after combined organ and hematopoietic cell transplantation.
    Strober S
    Blood Cells Mol Dis; 2008; 40(1):48-54. PubMed ID: 17827036
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Ability of donor splenocytes with costimulation blockade to induce mixed hematopoietic chimerism and transplantation tolerance.
    Shirasugi N; Emmanouilidis N; Pearson TC; Larsen CP
    Transplant Proc; 2004 Oct; 36(8):2423-4. PubMed ID: 15561267
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Fetal immune suppression as adjunctive therapy for in utero hematopoietic stem cell transplantation in nonhuman primates.
    Shields LE; Gaur L; Delio P; Potter J; Sieverkropp A; Andrews RG
    Stem Cells; 2004; 22(5):759-69. PubMed ID: 15342940
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Immune reconstitution after cord blood transplants supported by coinfusion of mobilized hematopoietic stem cells from a third party donor.
    Martín-Donaire T; Rico M; Bautista G; Gonzalo-Daganzo R; Regidor C; Ojeda E; Sanjuán I; Forés R; Ruiz E; Krsnik I; Navarro B; Gil S; Magro E; Millán I; Sánchez R; Pérez-Sanz N; Panadero N; García-Marco JA; Cabrera R; Fernández MN
    Bone Marrow Transplant; 2009 Aug; 44(4):213-25. PubMed ID: 19252533
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Efficient engraftment of in utero transplanted mice with retrovirally transduced hematopoietic stem cells.
    Rio P; Martinez-Palacio J; Ramirez A; Bueren JA; Segovia JC
    Gene Ther; 2005 Feb; 12(4):358-63. PubMed ID: 15550924
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Long-term survival of xenogeneic heart grafts achieved by costimulatory blockade and transient mixed chimerism.
    Murakami M; Ito H; Harada E; Enoki T; Sykes M; Hamano K
    Transplantation; 2006 Jul; 82(2):275-81. PubMed ID: 16858292
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Kidney transplantation in the United States.
    Cecka JM
    Clin Transpl; 2008; ():1-18. PubMed ID: 19711510
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Results of a pilot study on the use of third-party donor mesenchymal stromal cells in cord blood transplantation in adults.
    Gonzalo-Daganzo R; Regidor C; Martín-Donaire T; Rico MA; Bautista G; Krsnik I; Forés R; Ojeda E; Sanjuán I; García-Marco JA; Navarro B; Gil S; Sánchez R; Panadero N; Gutiérrez Y; García-Berciano M; Pérez N; Millán I; Cabrera R; Fernández MN
    Cytotherapy; 2009; 11(3):278-88. PubMed ID: 19308773
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Unrelated cord blood and mismatched unrelated volunteer donor transplants, two alternatives in patients who lack an HLA-identical donor.
    Ringdén O; Okas M; Uhlin M; Uzunel M; Remberger M; Mattsson J
    Bone Marrow Transplant; 2008 Nov; 42(10):643-8. PubMed ID: 18762760
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Combined bone marrow and peripheral blood progenitor cell autografts for patients with poor mobilization.
    Sinitsyn Y; Malone A; Mandeli J; Grosskreutz C; Osman K; Scigliano E; Shi P; Isola L
    Cytotherapy; 2009; 11(4):457-63. PubMed ID: 19499401
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Risk factor analysis of outcomes after unrelated cord blood transplantation in patients with hurler syndrome.
    Boelens JJ; Rocha V; Aldenhoven M; Wynn R; O'Meara A; Michel G; Ionescu I; Parikh S; Prasad VK; Szabolcs P; Escolar M; Gluckman E; Cavazzana-Calvo M; Kurtzberg J;
    Biol Blood Marrow Transplant; 2009 May; 15(5):618-25. PubMed ID: 19361754
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Postnatal booster injections increase engraftment after in utero stem cell transplantation.
    Milner R; Shaaban A; Kim HB; Fichter C; Flake AW
    J Surg Res; 1999 May; 83(1):44-7. PubMed ID: 10210641
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Enhanced in vivo motility of human umbilical cord blood hematopoietic stem/progenitor cells introduced via intra-bone marrow injection into xenotransplanted NOD/SCID mouse.
    Gao J; Li Y; Lu S; Wang M; Yang Z; Yan X; Zheng Y
    Exp Hematol; 2009 Aug; 37(8):990-7. PubMed ID: 19481136
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Peripheral blood or bone marrow cells in reduced-intensity or myeloablative conditioning allogeneic HLA identical sibling donor transplantation for multiple myeloma.
    Gahrton G; Iacobelli S; Bandini G; Björkstrand B; Corradini P; Crawley C; Hegenbart U; Morgan G; Kröger N; Schattenberg A; Schönland SO; Verdonck LF; Volin L; de Witte T; Niederwieser D;
    Haematologica; 2007 Nov; 92(11):1513-8. PubMed ID: 18024400
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Allogeneic intra-BM-BMT plus adult thymus transplantation from same donor has benefits for long-term survival even after sublethal irradiation or low-dose BM cell injection.
    Nishida T; Hosaka N; Takaki T; Miyake T; Cui W; Inaba M; Kinoshita H; Matsuda T; Ikehara S
    Bone Marrow Transplant; 2009 Jun; 43(11):829-37. PubMed ID: 19079314
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Mixed chimerism achieved by a nonlethal conditioning regimen induces donor-specific tolerance to lung allografts.
    Li S; Salgar SK; Kurimoto Y; Yousem S; Pham SM
    J Surg Res; 2008 May; 146(2):289-97. PubMed ID: 18314139
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Comparable long-term survival after bone marrow versus peripheral blood progenitor cell transplantation from matched unrelated donors in children with hematologic malignancies.
    Meisel R; Laws HJ; Balzer S; Bernbeck B; Kramm C; Schönberger S; Sinha K; Tröger A; Schmitz M; Fischer J; Göbel U; Enczmann J; Dilloo D
    Biol Blood Marrow Transplant; 2007 Nov; 13(11):1338-45. PubMed ID: 17950920
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Hematopoietic stem cell engraftment by early-stage in utero transplantation in a mouse model.
    Chen X; Gong XL; Katsumata M; Zeng YT; Huang SZ; Zeng F
    Exp Mol Pathol; 2009 Dec; 87(3):173-7. PubMed ID: 19666020
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The use of CD 34(+) mobilized peripheral blood as a donor cell source does not improve chimerism after in utero hematopoietic stem cell transplantation in non-human primates.
    Shields LE; Gaur L; Delio P; Gough M; Potter J; Sieverkropp A; Andrews RG
    J Med Primatol; 2005 Aug; 34(4):201-8. PubMed ID: 16053498
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.